TL;DR
Researchers have developed a novel "real-time bimodal" (RTBM) neural probe that can simultaneously measure the concentrations of four key neurochemicals (glucose, lactate, choline, and glutamate) and electrical neural activity in real-time, across multiple brain regions. This breakthrough overcomes previous limitations in crosstalk and temporal resolution, offering a powerful new tool for understanding brain function and developing treatments for neurological disorders.
What Problem Does This Paper Address?
Understanding the intricate workings of the brain, especially in the context of diseases like Parkinson's or schizophrenia, requires observing how neural circuits function. This involves not only measuring the electrical "chatter" of neurons but also tracking the chemical messengers (neurochemicals) that modulate their activity. Previous methods for measuring neurochemicals in vivo have faced significant hurdles:
- Limited Scope: Many systems could only monitor one or a few neurochemicals at a time.
- Crosstalk: Sensors often interfered with each other, leading to inaccurate readings.
- Poor Temporal Resolution: Measuring neurochemical changes in real-time was difficult, with sampling times often taking minutes.
- Inability to Combine with Electrophysiology: Crucially, most neurochemical monitoring techniques couldn't be integrated with the simultaneous recording of electrical brain activity, which is essential for understanding neural circuit dynamics.
This paper addresses the need for a single, integrated system that can overcome these limitations, providing high-resolution, real-time, multi-neurochemical, and electrophysiological data from multiple brain regions simultaneously.
Methods
The core innovation is the Real-Time Bimodal (RTBM) neural probe, built using microelectromechanical systems (MEMS) technology. Key methodological aspects include:
- Monolithic Integration: Biosensors for neurochemical detection are fabricated directly onto the probe body, minimizing size and complexity.
- Multi-Shank Design: The probe features multiple shanks, allowing for simultaneous measurements in different brain regions. This is crucial for studying functional connectivity between areas.
- Microfluidic Channels: Integrated microfluidic channels are used for:
- ECF Extraction: Gently extracting extracellular fluid (ECF) from the brain tissue.
- Buffer/Drug Delivery: Delivering artificial cerebrospinal fluid (aCSF) to maintain tissue health or introducing drugs for targeted neuromodulation.
- Controlled Flow: Precisely controlling fluid flow (push-pull perfusion) to ensure consistent sample delivery to biosensors and minimize delays.
- Enzyme-Based Biosensors: Each biosensor utilizes specific enzymes to selectively detect target neurochemicals. The paper details the use of glucose oxidase, lactate oxidase, choline oxidase, and glutamate oxidase.
- Three-Electrode System: Each biosensor employs a standard three-electrode setup (working, reference, and counter electrodes) for electrochemical detection of the enzymatic reaction products.
- Parallel Sensor Arrangement: Biosensors are arranged in parallel within microfluidic chambers to prevent crosstalk between sensors.
- Colocalized Recording Electrodes: Electrical recording electrodes are placed close to the neurochemical sampling sites, ensuring that electrical and chemical signals are captured from the same local environment.
The fabrication process involves standard MEMS techniques, including microfluidic channel fabrication, enzyme coating using a custom PDMS well array for selective application, and integration with an interface chip and tubing for fluid control.
Datasets
Not discussed in the paper. The experiments utilize in vivo measurements from live mice and ex vivo acute brain slices.
Key Insights and Ideas
- Eliminating Crosstalk: The parallel arrangement of biosensors and careful microfluidic design effectively prevents cross-contamination between sensor readings, a major hurdle in previous multi-analyte sensors.
- Bridging Electrical and Chemical Signals: The RTBM probe's ability to simultaneously record both electrical activity and neurochemical concentrations in the same brain region is a significant leap. This allows researchers to directly correlate neural firing patterns with the release and uptake of specific neurotransmitters and metabolites.
- Functional Connectivity Revealed: By implanting the probe in two connected brain regions (mPFC and mediodorsal thalamus) and stimulating one region, the researchers could observe how activity and neurochemical changes propagated, providing insights into neural circuit connectivity.
- Versatility and Expandability: The modular design allows for easy reconfiguration of target neurochemicals by swapping enzymes and can be scaled up with more shanks or biosensors.
Key Results
- Simultaneous Measurement: The probe successfully measured four neurochemicals (glucose, lactate, choline, and glutamate) and electrical activity concurrently in real-time, without crosstalk.
- Response Time: The biosensors showed a response time of approximately 20 seconds to reach 90% of their final current value after a stimulus.
- Sensitivity: The probe demonstrated sufficient sensitivity to detect neurochemical changes induced by electrical stimulation and KCl-induced neuromodulation in vivo. For example, KCl injection led to significant increases in lactate (up to 236.3%), choline (up to 148.8%), and glutamate (up to 140.0%), while glucose decreased by 8.2%.
- Functional Connectivity: In experiments investigating the mPFC-MD pathway, KCl stimulation in the mPFC led to a rapid increase in neural activity and glutamate concentration in the MD region, suggesting functional connectivity.
- Drug Selectivity: The probe's selectivity was confirmed by demonstrating that DL-TBOA, a glutamate reuptake inhibitor, selectively increased glutamate concentration without affecting other measured neurochemicals.
Limitations and Future Work
- Response Time: While improved, the 20-second response time for neurochemicals might still be a limitation for capturing extremely rapid transient events. The authors suggest that reducing the stimulated region and duration could help.
- Baseline Drift: The authors acknowledge potential baseline drift in current due to equipment instability, which needs to be addressed for more precise basal level measurements.
- In Vivo Neuromodulation: While the probe can deliver drugs, the current experiments focused on KCl stimulation. Future work could explore more complex drug delivery and monitoring of drug efficacy.
- Behavioral Studies: The authors envision future work involving concurrent monitoring of bimodal signals in behaving animals to link behaviors, neural activity, and neurochemical changes.
- Wireless Integration: Developing a wireless version of the system would greatly enhance its utility for freely moving animals.
- Broader Biosensor Integration: The platform is amenable to integrating other biosensor types (e.g., antigen-antibody reactions, fluorescent assays) for detecting a wider range of biomarkers.
Summary updated